RecruitingPhase 3NCT06975865
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Sponsor: Sanofi
Portland, OR · +20 more sites
1 recruiting sickle cell disease studies with a site in Portland, OR.
Sponsor: Sanofi
Portland, OR · +20 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.